Follow
Didem Naz DIOKEN
Didem Naz DIOKEN
Verified email at metu.edu.tr
Title
Cited by
Cited by
Year
EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers
E Cicek, A Circir, M Oyken, O Akbulut Caliskan, DN Dioken, ...
Oncogene 41 (2), 220-232, 2022
102022
Identification of an mRNA isoform switch for HNRNPA1 in breast cancers
M Erdem, İ Ozgul, DN Dioken, I Gurcuoglu, S Guntekin Ergun, ...
Scientific Reports 11 (1), 24444, 2021
72021
AC‐term truncated EIF2Bγ protein encoded by an intronically polyadenylated isoform introduces unfavorable EIF2Bγ–EIF2γ interactions
A Circir, G Koksal Bicakci, B Savas, DN Doken, ŞO Henden, T Can, ...
Proteins: Structure, Function, and Bioinformatics 90 (3), 889-897, 2022
22022
An alternatively spliced PD-L1 isoform PD-L1∆ 3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
DN Dioken, I Ozgul, I Yilmazbilek, MC Yakicier, E Karaca, ...
Cancer Immunology, Immunotherapy 72 (12), 4065-4075, 2023
12023
Differential expression of mRNA 3′-end isoforms in cervical and ovarian cancers
DN Dioken, I Ozgul, GK Bicakci, K Gol, T Can, AE Erson-Bensan
Heliyon 9 (9), 2023
12023
HNRNPA1 Isoform Switch in Breast Cancers
AE Erson Bensan, İ Özgül, M Erdem, DN Döken
2021
The system can't perform the operation now. Try again later.
Articles 1–6